Increased low-density lipoprotein peroxidation in elderly men

Coronary Artery Disease

Volumn 8, Issue 3-4, 1997, Pages 129-136

  Napoli, Claudio ^a,d   Abete, Pasquale ^a   Corso, Gaetano ^a   Malorni, Antonio ^b   Postiglione, Alfredo ^a   Ambrosio, Giuseppe ^c   Cacciatore, Francesco ^a   Rengo, Franco ^a   Palumbo, Giuseppe ^a  

^a CNR   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d NONE   (Italy)

Author keywords

Aging; Arachidonic acid; Low density lipoprotein; Oxidation; Oxygen radicals; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; THIOBARBITURIC ACID;

ADULT; AGED; AGING; ARTICLE; ATHEROGENESIS; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; HUMAN; HUMAN EXPERIMENT; LIPID PEROXIDATION; MALE; PRIORITY JOURNAL;

EID: 0030989324     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199703000-00002     Document Type: Article

References (38)

1. The Expert Panel: Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 1993, 269:3015-3023.
2. Denke MA, Grundy SM: Hypercholesterolemia in elderly persons: resolving the treatment dilemma. Ann Intern Med 1990, 112:780-792.
3. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, et al.: Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995, 91:2488-2496.
4. Laurenzi M, Mancini M: Plasma lipids in elderly men and women. Eur Heart J 1988, 9 (suppl D):69-74.
5. Knopp RH, Warnick GR, Waiden CE, Wahl PW, Hoover JJ, Bergelin RO, et al.: Relationship of gender, sex hormone use and age with lipoprotein cholesterol. Atherosclerosis 1981, 39:133-135.
6. Lecerf J, Rossignol A, Varicel E, Thies F, Farmer M, Logarde M: Variations in the fatty acid composition of lipid classes from lipoproteins in elderly women. Atherosclerosis 1993, 98:241-249.
7. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol. Modifications of low density lipoprotein that increase its atherogenicity. N Engl J Med 1989, 320:915-924.
8. Berliner JA, Heinecke JW: The role of oxidized lipoproteins in atherogenesis. Free Radical Biol Med 1996, 20:707-727.
9. 4 intoxication, and vitamin E deficiency. Biochem Med 1980, 23:302-311.
10. Takeuchi N, Tanaka F, Katayama Y: Effect of tocopherol on thiobarbituric acid reactive substances in serum and hepatic subcellular organelles, and lipid metabolism. Exp Gerontol 1976, 11:179-185.
11. Knigh JA, Smith SE, Kinder VE, Anstall HB: Reference intervals for plasma lipoperoxides: age, sex, and specimen-related variations. Clin Chem 1987, 33:2289-2291.
12. Maziere C, Auclair M, Ronveaux M, Salmon S, Santus R, Maziere J: Estrogens inhibit copper and cell-mediated modification of low density lipoprotein. Atherosclerosis 1991, 89:175-182.
13. Sack MN, Rader DJ, Cannon RO: Oestrogen and inhibition of oxidation of low density lipoproteins in postmenopausal women. Lancet 1994, 343:269-270.
14. Schmuck A, Fuller CJ, Devaraj S, Jialal I: Effect of aging on susceptibility of low density lipoproteins to oxidation. Clin Chem 1995, 41:1628-1632.
15. Chung BH, Wilkinson T, Geer JC, Segrest JP. Preparative and quantitative isolation of plasma lipoproteins: rapid single discontinuous density gradient ultracentrifugation in a vertical rotor. J Lipid Res 1980, 21:284-291.
16. Napoli C, Ambrosio G, Palumbo G, Elia PP, Chiariello M: Atherogenic oxidative modification of human lipoproteins may involve peroxidative chain reactions following initial oxygen free radicals attack. J Mol Cell Cardiol 1991, 23 (suppl V):115A-128B.
17. Ambrosio G, Oriente A, Napoli C, Palumbo G, Chiariello P, Marone G, et al.: Oxygen radical inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet activating factor. J Clin Invest 1994, 93:2408-2416.
18. Napoli C, Postiglione A, Triggiani M, Corso G, Palumbo G, Carbone V, et al.: Oxidative structural modifications of low density lipoproteins in homozygous familial hypercholesterolemia. Atherosclerosis 1995, 118:259-273.
19. Napoli C, Chiariello M, Palumbo G, Ambrosio G: Calcium channel blockers inhibit human low density lipoprotein oxidation by oxygen radicals. Cardiovasc Drug Ther 1996, 10:417-424.
20. Napoli C, Mancini FP, Corso G, Malorni A, Crescenzi E, Postiglione A, et al.: A simple and rapid procedure of low density lipoprotein and lipoprotein (a) purification minimizes oxygen radical-induced modifications. Biochemistry 1997, in press.
21. Lowry OH, Rosebrough HJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 1951, 193:265-275.
22. Folch J, Lees M, Sloane-Stanley GH: A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem 1957, 226:497-505.
23. Kaluzny MA, Duncan LA, Merritt MV, Epps DE: Rapid separation of lipid classis in high yield and purity using bonded phase columns. J Lipid Res 1985, 26:135-142.
24. Dieber-Rotheneder M, Puhl H, Waeg G, Striegl G, Esterbauer H: Effect of oral supplementation with a-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res 1991, 32:1325-1331.
25. Esterbauer H, Streigl G, Puhl H, Rotheneder M: Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radical Res Commun 1989, 6:67-75.
26. Buege JA, Aust SD: Microsomal lipid peroxidation. Methods Enzymol 1978; 52:302-310.
27. Halliwell B, Chirico S: Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 1993, 57:715S-725S.
28. Rifici VA, Khachadurian AK: The inhibition of low density lipoprotein oxidation by 17 β-estradiol. Metabolism 1992, 41:1110-1114.
29. Scheek LM, Wiseman SA, Tijburg LBM, van Tol A: Dialysis of isolated low density lipoprotein induces a loss of lipophilic antioxidants and increases the susceptibility to oxidation in vitro. Atherosclerosis 1995, 117:139-144.
30. Napoli C: Low density lipoprotein oxidation and variant angina: role of methodologic procedures in assessment of oxidizability of low density lipoprotein. J Am Coll Cardiol 1996, 28:1637-1638.
31. Napoli C, Ambrosio G, Scarpato N, Corso G, Palumbo G, D'Armiento FP, et al.: Decreased low-density lipoprotein oxidation after repeated selective apheresis in homozygous familial hypercholesterolemia. Am Heart J 1997, 133:585-595.
32. Choe M, Jacson C, Yu BP: Lipid peroxidation contributes to age-related membrane rigidity. Free Radical Biol Med 1995, 18:977-984.
33. Zimetbaum P, Frishman WH, Ooi WL. for the Bronx Aging Study: Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. Arterioscler Thromb 1992, 12:416-423.
34. Assmann G, Schulte H: Relation of high density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (The PROCAM experience). Am J Cardiol 1992, 70:733-737.
35. Stephens NG, Parsons A, Schonfeld PM for the Randomised Controlled Trial of Vitamin E in Patients with Coronary Disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996, 347:781-786.
36. Stephens NG, Parsons A, Mitchinson M, Brown M: The influence on serum vitamin E on cardiac risk in patients with advanced coronary disease: data from the CHAOS trial [abstract]. J Am Coll Cardiol 1997, 29 (suppl A):86A.
37. Jha P, Flather M, Lonn E, Farkouh M, Yasuf S: The antioxidant vitamins and cardiovascular disease. A critical review of epidemiological and clinical trial data. Ann Intern Med 1995, 123:860-872.
38. Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group: The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994, 330:1029-1035.